17-40126289-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001365919.1(MSL1):c.875A>G(p.Glu292Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,613,914 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001365919.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSL1 | NM_001365919.1 | c.875A>G | p.Glu292Gly | missense_variant | Exon 2 of 9 | ENST00000398532.9 | NP_001352848.1 | |
MSL1 | NM_001365920.1 | c.875A>G | p.Glu292Gly | missense_variant | Exon 2 of 8 | NP_001352849.1 | ||
MSL1 | NM_001365921.2 | c.875A>G | p.Glu292Gly | missense_variant | Exon 2 of 3 | NP_001352850.1 | ||
MSL1 | NM_001012241.2 | c.86A>G | p.Glu29Gly | missense_variant | Exon 3 of 10 | NP_001012241.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000802 AC: 2AN: 249264Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135230
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461706Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727136
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.86A>G (p.E29G) alteration is located in exon 3 (coding exon 1) of the MSL1 gene. This alteration results from a A to G substitution at nucleotide position 86, causing the glutamic acid (E) at amino acid position 29 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at